Orphan Drug Companies Warned To Beware Of The Dutch Lock System
Executive Summary
Companies selling orphan medicines in the Netherlands need to prepare for the likelihood that their products will enter the so-called lock system, which means they will come under extra scrutiny and take longer to reach patients.